Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University Hospital, Angers | OTHER_GOV |
Not provided
Not provided
Not provided
Not provided
Prospective multicenter open-label randomized clinical trial comparing videoconsultation to a face-to-face consultation during the follow-up of apneic patients treated by continuous positive pressure (CPAP) .
The annual management of Obstructive Sleep Apnea (OSA) patients treated by continuous positive air pressure (CPAP) aims to maintain an optimal level of care while offering to the patients a combined management of their pathology. This management aims to reduce the risk of cardio-metabolic pathologies.
However, the high prevalence of OSA in the general population reduces the ability to explore undiagnosed patients. The contribution of videoconsultation is now available and allows the management of OSA patients treated by CPAP.
The objective of this study is to compare the videoconsultation to a face-to-face consultation during the follow-up of apneic patients treated by continuous positive pressure (CPAP) .
The results of this study could provide very important new data on the impact of videoconsultation on the monitoring a chronic respiratory pathology such as sleep apnea.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Video consultation | Other | Patients in this group will have a continuous positive pressure follow-up visit by videoconsultation |
|
| Face-to-face consultation | No Intervention | Patients in this group will have a continuous positive pressure follow-up visit by face-to-face consultation |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Videoconsultation | Other | Patient randomized on video-consultation group will have a video-consultation with the investigator within 3 months after the randomization. During this consultation, the investigator performs a clinical interrogation in order to collect anthropometric parameters: (sex, age, weight, height, body mass index (BMI)), blood pressure (by blood pressure monitor at home), the level of physical activity (by Actimetry over 7 days), smoking status and alcohol status |
| Measure | Description | Time Frame |
|---|---|---|
| Therapeutic adherence to CPAP | Non inferiority of visioconsultation compared to face-to-face consultation in terms of therapeutic adherence to CPAP evaluated by the difference in compliance 3 months before and 3 months after the consultation | 3 months after consultation |
| Consultation cost | Non inferiority of visioconsultation compared to face-to-face consultation in terms of consultation cost evaluated by the difference in cost between the 2 types of consultation | 3 months after consultation |
| Patient satisfaction: questionnaire | Non inferiority of visioconsultation compared to face-to-face consultation in terms of patient satisfaction evaluated by the VSQ-VF questionnaire | 3 months after consultation |
| Measure | Description | Time Frame |
|---|---|---|
| Sleepiness related to CPAP | Epworth Sleepiness Scale | 3 and 12 after consultation |
| Tiredness related to CPAP | Pichot's fatigue scale |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Marie JOYEUX-FAURE, Dr | Contact | +33 (0)4.76.76.71.66 | mjoyeuxfaure@chu-grenoble.fr | |
| Renaud TAMISIER, Pr | Contact | +33 (0)4.76.76.84.69 | rtamisier@chu-grenoble.fr |
| Name | Affiliation | Role |
|---|---|---|
| Renaud TAMISIER, Pr | University Hospital, Grenoble | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CHU Grenoble-Alpes | Recruiting | Grenoble | 38043 | France |
Not provided
| ID | Term |
|---|---|
| D020181 | Sleep Apnea, Obstructive |
| ID | Term |
|---|---|
| D012891 | Sleep Apnea Syndromes |
| D001049 | Apnea |
| D012120 | Respiration Disorders |
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| 3 and 12 months after consultation |
| Evaluate the quality of CPAP treatment (Residual AHI) | Evaluate the quality of CPAP treatment by the residual Apnea-Hypopnea Index(AHI) (event/hour) | 3 and 12 months after consultation |
| Evaluate the quality of CPAP treatment (adverse events) | Evaluate the quality of CPAP treatment by the adverse event reporting | 3 and 12 months after consultation |
| Evaluate the quality of CPAP treatment (mask leaks level) | Evaluate the quality of CPAP treatment by the CPAP mask leaks level (litre/min) | 3 and 12 months after consultation |
| Evaluate the quality of CPAP treatment (visits by the health care provider): number of visits by the health care provider and the reasons for these visits | Evaluate the quality of CPAP treatment by collecting the number of visits by the health care provider and the reasons for these visits | 3 and 12 months after consultation |
| Assess the risk factors associated with OSA in patients treated with CPAP (weight) | Body weight (kg) | 12 months after consultation |
| Assess the risk factors associated with OSA in patients treated with CPAP (level of physical activity) | Evaluation of the level of physical activity by actimetry | 12 months after consultation |
| Assess the risk factors associated with OSA in patients treated with CPAP (blood pressure) | Blood pressure by blood pressure monitoring at home | 12 months after consultation |
| D020919 |
| Sleep Disorders, Intrinsic |
| D020920 | Dyssomnias |
| D012893 | Sleep Wake Disorders |
| D009422 | Nervous System Diseases |